KKAMG
BIIB icon

Kernodle & Katon Asset Management Group’s Biogen BIIB Stock Holding History

Kernodle & Katon Asset Management Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$10K Hold
37
– – 0.01% 223
2016
Q4 		$10K Sell
37
-88
-70% -$26.1K 0.01% 218
2016
Q3 		$39K Sell
125
-25
-17% -$7.4K 0.02% 194
2016
Q2 		$36K Buy
150
+6
+4% +$1.58K 0.03% 152
2016
Q1 		$37K Buy
144
+19
+15% +$5.02K 0.04% 138
2015
Q4 		$38K Buy
+125
New +$35.9K 0.04% 139

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kernodle & Katon Asset Management Group's BIIB Position: Q1 2017 in Review

Kernodle & Katon Asset Management Group held its Biogen (BIIB) position steady in Q1 2017 at 37 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #223.

Kernodle & Katon Asset Management Group first reported a position in BIIB in Q4 2015 and has held it in 6 quarters since. The position peaked at $39K in Q3 2016. 1,019 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

  • Kernodle & Katon Asset Management Group held 37 shares of Biogen worth $10K as of Q1 2017.
  • Kernodle & Katon Asset Management Group left its Biogen share count unchanged in Q1 2017.
  • Biogen made up 0.01% of Kernodle & Katon Asset Management Group's portfolio in Q1 2017, its #223 holding.
  • Kernodle & Katon Asset Management Group first reported a position in Biogen in Q4 2015 and has held it in 6 quarters since.
  • Kernodle & Katon Asset Management Group's Biogen position peaked at $39K in Q3 2016.
  • 1,019 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on Kernodle & Katon Asset Management Group's 13F filing for Q1 2017, filed 12 May 2017.